Detalhe da pesquisa
1.
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.
Cancer Immunol Immunother
; 73(7): 124, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727837
2.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study.
Lancet Oncol
; 24(5): 483-495, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080222
3.
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 24(6): 646-657, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182538
4.
A Phase IIb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer who received at least two prior treatments.
Int J Cancer
; 152(10): 2134-2144, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621000
5.
Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.
BMC Med
; 21(1): 300, 2023 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37559142
6.
An artificial neural network model based on DNA damage response genes to predict outcomes of lower-grade glioma patients.
Brief Bioinform
; 22(6)2021 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34015817
7.
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1-3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial.
Invest New Drugs
; 41(6): 808-815, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889382
8.
Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells.
Cell Commun Signal
; 21(1): 59, 2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36915147
9.
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.
JAMA
; 330(21): 2064-2074, 2023 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051328
10.
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial.
Lancet Oncol
; 23(9): 1167-1179, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908558
11.
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
Mol Cancer
; 21(1): 4, 2022 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980131
12.
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial.
JAMA
; 328(12): 1223-1232, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166026
13.
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China.
Chin J Cancer Res
; 34(6): 592-600, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36714346
14.
Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN-PI3K-AKT signalling pathway in gastric cancer.
J Cell Mol Med
; 25(18): 8890-8903, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382342
15.
Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.
BMC Cancer
; 21(1): 700, 2021 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34126950
16.
Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI.
BMC Med Imaging
; 21(1): 155, 2021 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688263
17.
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
Cancer
; 126 Suppl 16: 3867-3882, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710660
18.
Polydopamine Coated PB-MnO2 Nanoparticles as an Oxygen Generator Nanosystem for Imaging-Guided Single-NIR-Laser Triggered Synergistic Photodynamic/Photothermal Therapy.
Bioconjug Chem
; 31(5): 1474-1485, 2020 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286806
19.
Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy.
Biomacromolecules
; 21(2): 921-929, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31961134
20.
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(6): 806-815, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036468